![September 2023: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection](https://icap.columbia.edu/wp-content/uploads/JC-2023-photo-973x675.jpg)
Thailand
![September 2023: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection](https://icap.columbia.edu/wp-content/uploads/JC-2023-photo-973x675.jpg)
![February 2022: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children](https://icap.columbia.edu/wp-content/uploads/istock1-1080x675.png)
February 2022: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children
Article and Study Summary: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children Published in: New England Journal of Medicine 2021,385(27):2531-2543. https://www.nejm.org/doi/full/10.1056/NEJMoa2108793 Authors: Turkova A, White E, Mujuru HA,...![May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis](https://icap.columbia.edu/wp-content/uploads/0-3-e1622128820264-1080x675.png)
May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...![Human Immunodeficiency Virus Infection in Adolescents and Mode of Transmission in Southern Africa: A Multinational Analysis of Population-Based Survey Data](https://icap.columbia.edu/wp-content/uploads/GettyImages-1215740359-e1620659768220-1080x675.jpg)
Human Immunodeficiency Virus Infection in Adolescents and Mode of Transmission in Southern Africa: A Multinational Analysis of Population-Based Survey Data
Andrea Low, Chloe Teasdale, Kristin Brown, Danielle T Barradas, Owen Mugurungi, Karam Sachathep, Harriet Nuwagaba-Biribonwoha, Sehin Birhanu, Andrew Banda, Koen Frederix, Danielle Payne, Elizabeth Radin, Lubbe Wiesner, Choice Ginindza, Neena Philip, Godfrey Musuka,...![April 2021: IMPAACT 2010/VESTED trial evaluates the virological efficacy and safety of ART regimens containing DTG when started in pregnancy](https://icap.columbia.edu/wp-content/uploads/GettyImages-1208393752-1-e1619719000287-1080x675.jpg)